Bacterial News and Research

RSS

Cholera-causing bacteria and viruses locked in evolutionary arms race

Cholera-causing bacteria are locked in an evolutionary arms race with a viral nemesis, according to a new genomic study.

1 Apr 2026

Gut microbiome changes improve memory in early cognitive decline

Research shows that modifying the gut microbiome can enhance cognitive performance and mitigate dementia risk, highlighting the gut-brain connection.

1 Apr 2026

Fiber supplement stabilizes blood sugar in gestational diabetes

Dietary fiber supplementation shows potential in managing blood sugar levels and preventing preterm births in pregnancies at risk for gestational diabetes.

1 Apr 2026

Gut bacteria determine fiber benefits in celiac disease patients

Many people with celiac disease are advised to eat more fiber to support digestion and manage symptoms, either through diet or prescribed fiber supplements.

31 Mar 2026

New T cell mechanism could lead to longer-lasting vaccines

Researchers at the University of Wisconsin School of Veterinary Medicine have identified a possible way to make longer lasting vaccines for respiratory viruses like influenza and the coronavirus that causes COVID-19.

31 Mar 2026

Restoring tissue stiffness may reduce inflammation in gum disease

Periodontitis is a serious chronic inflammatory form of gum disease that affects millions worldwide. It can lead to tooth loss and the destruction of supporting bone.

31 Mar 2026

Why vaginal microbiota transplants aren’t working yet

Vaginal microbiota transplantation without antibiotics fails to restore microbiome balance, yet engraftment suggests avenues for enhancing treatment efficacy.

31 Mar 2026

Dropped surgical implants are contaminated instantly and alcohol does not fix it

A study evaluates disinfectants for decontaminating dropped implants in surgery, highlighting risks and the efficacy of CHG and PI in reducing bacterial load.

31 Mar 2026

How do diet, smoking, alcohol, and stress reshape the female microbiome?

This review examines how modifiable lifestyle and environmental factors shape the female vaginal, gut, oral, and skin microbiomes, with diet, alcohol, smoking, obesity, stress, hygiene, physical activity, and sexual behaviours all linked to site-specific microbial shifts. It argues that understanding these patterns could help guide future female-focused prevention and intervention strategies.

30 Mar 2026

New urine test shows which UTI antibiotic works in under six hours

Researchers have developed a rapid direct-from-urine test that identifies which first-line antibiotic is likely to work for a urinary tract infection in an average of 5.85 hours, instead of the usual two to three days. In studies of 352 routine urine samples and 90 duplicate preservative-tested samples, the method showed high agreement with standard testing, suggesting it could speed treatment and support efforts to curb antimicrobial resistance.

30 Mar 2026

Inside the high-stakes corporate fight over feeding preterm babies

In 2013, a scientist at Abbott Laboratories saw study results with potentially big implications for the company's profits and the lives of some of the world's most fragile people: preterm infants.

30 Mar 2026

Study reveals how a promising bacterial therapy reduces recurrent bacterial vaginosis

A new study from the Kwon Lab at the Ragon Institute, published in Cell Host & Microbe, provides the most detailed picture yet of how a promising bacterial therapy works to prevent recurrent bacterial vaginosis (BV) and why it works better for some women than others.

27 Mar 2026

FDA approves first gene therapy for rare pediatric immune disorder

Dr. Donald Kohn has been developing gene therapies for rare pediatric immune disorders for over 30 years.

27 Mar 2026

New AI tool assesses the potential threat posed by new bacteria

Researchers have developed an AI tool that can help determine whether unfamiliar bacteria carry genetic features linked to disease.

27 Mar 2026

Do multi-strain probiotics improve long covid symptoms?

Multi-strain probiotics show potential to modulate gut microbiome in long COVID, yet their impact on inflammation and recovery is not statistically significant.

27 Mar 2026

Study links higher enteric disease risk to E. coli in high-risk water supplies

A nationwide New Zealand study found no significant overall link between most routine drinking water quality indicators and enteric disease risk, but E. coli signals emerged in higher-risk settings such as surface-water supplies, systems with known source-water risks, and periods of heavy rainfall. The findings suggest that sporadic bacterial enteric disease may sometimes be linked to drinking water contamination, especially in vulnerable systems, while also highlighting important limitations and the need for targeted monitoring.

26 Mar 2026

Chlorhexidine reduces umbilical cord infections in newborns

A new Cochrane review finds that chlorhexidine likely cuts umbilical cord infection rates by about 29% in low- and middle-income countries, and may reduce newborn deaths.

25 Mar 2026

Can camel milk improve health? Review highlights benefits but warns against drinking it raw

A narrative review in Food Science & Nutrition examined studies published from 2000 to 2025 and found that camel milk contains bioactive compounds with potential glycemic, anti-inflammatory, gut, and other health benefits. It also stressed that raw, unpasteurized camel milk poses microbial and zoonotic risks, underscoring that safety remains a key part of the story.

25 Mar 2026

Genetic study maps bacteria’s protective armor behind severe infections

The first large-scale genetic study of E. coli's protective armor has identified the five capsule types that are responsible for 70 per cent of all multidrug-resistant bloodstream infections in Europe.

25 Mar 2026

Severe infections linked to higher dementia risk independent of coexisting illnesses

Severe infections increase the risk of dementia independently of other coexisting illnesses, according to a new study published March 24th in the open-access journal PLOS Medicine by Pyry Sipilä of the University of Helsinki, Finland, and colleagues.

24 Mar 2026